Previously, the company projected earnings per diluted share of $12.50 to $13, but the update range is $12.60 to $12.90.
Additionally, McKesson shared preliminary fiscal 2017 adjusted earnings per diluted share growth of 7 percent to 12 percent.
More articles on health IT:
Allscripts, Medfusion settle breach of contract dispute
Nurses benefit from telemedicine in the ICU: 5 survey findings
6 recent vendor contracts, go-lives
